Houston, TX, United States of America

Eleanor De Groot

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2016-2021

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Eleanor De Groot

Introduction

Eleanor De Groot is a prominent inventor based in Houston, TX (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled forms of anamorelin hydrochloride. With a total of 7 patents to her name, her work has had a substantial impact on drug formulation and delivery.

Latest Patents

Eleanor's latest patents focus on methods of producing anamorelin hydrochloride with controlled chloride content. The inventions relate to particulate forms of anamorelin monohydrochloride, which are isolated in an amorphous and/or fine particulate state. These processes are crucial for creating pharmaceutical compositions that ensure the efficacy and safety of the drug.

Career Highlights

Throughout her career, Eleanor has worked with notable companies such as Helsinn Healthcare and Ono Pharmaceutical Co., Ltd. Her expertise in pharmaceutical sciences has allowed her to contribute to innovative drug development processes that enhance therapeutic outcomes.

Collaborations

Eleanor has collaborated with esteemed colleagues in her field, including Shin-itsu Kuwabe and Takehiko Yanagimachi. These partnerships have fostered a collaborative environment that promotes the advancement of pharmaceutical innovations.

Conclusion

Eleanor De Groot's contributions to the pharmaceutical industry exemplify the importance of innovation in drug development. Her patents and collaborations reflect her commitment to improving healthcare through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…